Literature DB >> 28528776

Structural Basis of TPR-Mediated Oligomerization and Activation of Oncogenic Fusion Kinases.

Kuntal Pal1, Abhishek Bandyopadhyay1, X Edward Zhou1, Qingping Xu2, David P Marciano3, Joseph S Brunzelle4, Smitha Yerrum1, Patrick R Griffin3, George Vande Woude1, Karsten Melcher5, H Eric Xu6.   

Abstract

The nuclear pore complex subunit TPR is found in at least five different oncogenic fusion kinases, including TPR-MET, yet how TPR fusions promote activation of kinases and their oncogenic activities remains poorly understood. Here we report the crystal structure of TPR(2-142), the MET fusion partner of oncogenic TPR-MET. TPR(2-142) contains a continuous 124-residue α helix that forms an antiparallel tetramer from two leucine zipper-containing parallel coiled coils. Remarkably, single mutations cause strikingly different conformations of the coiled coil, indicating its highly dynamic nature. We further show that fusion of TPR(2-142) to the MET intracellular domain strongly and selectively stabilizes the αG helix of the MET kinase domain, and mutations of only the TPR leucine zipper residues at the junction to MET, but not other leucine zipper residues, abolish kinase activation. Together, these results provide critical insight into the TPR structure and its ability to induce dimerization and activation of fusion kinases.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  MET; oncogenic fusion kinase; receptor dimerization; receptor tyrosine kinase

Mesh:

Substances:

Year:  2017        PMID: 28528776      PMCID: PMC5507626          DOI: 10.1016/j.str.2017.04.015

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  53 in total

1.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

Review 2.  The structure of alpha-helical coiled coils.

Authors:  Andrei N Lupas; Markus Gruber
Journal:  Adv Protein Chem       Date:  2005

3.  Structural characterization of autoinhibited c-Met kinase produced by coexpression in bacteria with phosphatase.

Authors:  Weiru Wang; Adhirai Marimuthu; James Tsai; Abhinav Kumar; Heike I Krupka; Chao Zhang; Ben Powell; Yoshihisa Suzuki; Hoa Nguyen; Maryam Tabrizizad; Catherine Luu; Brian L West
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-28       Impact factor: 11.205

4.  Structural basis for selective small molecule kinase inhibition of activated c-Met.

Authors:  Keith W Rickert; Sangita B Patel; Timothy J Allison; Noel J Byrne; Paul L Darke; Rachael E Ford; David J Guerin; Dawn L Hall; Maria Kornienko; Jun Lu; Sanjeev K Munshi; John C Reid; Jennifer M Shipman; Elizabeth F Stanton; Kevin J Wilson; Jonathon R Young; Stephen M Soisson; Kevin J Lumb
Journal:  J Biol Chem       Date:  2011-01-18       Impact factor: 5.157

Review 5.  Helix capping.

Authors:  R Aurora; G D Rose
Journal:  Protein Sci       Date:  1998-01       Impact factor: 6.725

6.  Structural basis for agonism and antagonism of hepatocyte growth factor.

Authors:  W David Tolbert; Jennifer Daugherty-Holtrop; Ermanno Gherardi; George Vande Woude; H Eric Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

Review 7.  Oncogenic activation of tyrosine kinases.

Authors:  G A Rodrigues; M Park
Journal:  Curr Opin Genet Dev       Date:  1994-02       Impact factor: 5.578

8.  Disulfide recognition in an optimized threading potential.

Authors:  A A Dombkowski; G M Crippen
Journal:  Protein Eng       Date:  2000-10

Review 9.  From Tpr-Met to Met, tumorigenesis and tubes.

Authors:  P Peschard; M Park
Journal:  Oncogene       Date:  2007-02-26       Impact factor: 9.867

10.  Architecture and membrane interactions of the EGF receptor.

Authors:  Anton Arkhipov; Yibing Shan; Rahul Das; Nicholas F Endres; Michael P Eastwood; David E Wemmer; John Kuriyan; David E Shaw
Journal:  Cell       Date:  2013-01-31       Impact factor: 41.582

View more
  5 in total

Review 1.  The Structure of the Nuclear Pore Complex (An Update).

Authors:  Daniel H Lin; André Hoelz
Journal:  Annu Rev Biochem       Date:  2019-03-18       Impact factor: 23.643

Review 2.  Overcoming resistance to targeted therapy using MET inhibitors in solid cancers: evidence from preclinical and clinical studies.

Authors:  Nehad M Ayoub; Dalia R Ibrahim; Amer E Alkhalifa
Journal:  Med Oncol       Date:  2021-10-19       Impact factor: 3.064

Review 3.  Structure, activation and dysregulation of fibroblast growth factor receptor kinases: perspectives for clinical targeting.

Authors:  Brendan Farrell; Alexander L Breeze
Journal:  Biochem Soc Trans       Date:  2018-12-13       Impact factor: 5.407

4.  Identification of a novel HOOK3-FGFR1 fusion gene involved in activation of the NF-kappaB pathway.

Authors:  Xuehong Zhang; Furong Wang; Fanzhi Yan; Dan Huang; Haina Wang; Beibei Gao; Yuan Gao; Zhijie Hou; Jiacheng Lou; Weiling Li; Jinsong Yan
Journal:  Cancer Cell Int       Date:  2022-01-26       Impact factor: 5.722

5.  Case Report: Dramatic Response to Crizotinib in a Patient With Non-Small Cell Lung Cancer Positive for a Novel ARL1-MET Fusion.

Authors:  Qing Ma; Lingping Kong; Diansheng Zhong
Journal:  Front Oncol       Date:  2022-02-14       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.